Clinical Trial Update: Buprenorphine for Late-Life Treatment Resistant Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating buprenorphine for late-life treatment-resistant depression has completed. The results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: University of Pittsburgh | Conditions: Depression | Phase 2 | Status: COMPLETED | Results posted: 2016-03-17